Rekah Pharmaceutical Industry Ltd
TASE:REKA
Rekah Pharmaceutical Industry Ltd
Cash from Financing Activities
Rekah Pharmaceutical Industry Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Financing Activities
-₪7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-20%
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Financing Activities
-$1.4B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Financing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Financing Activities
-₪82.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Financing Activities
$22.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
241%
|
CAGR 10-Years
2%
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Cash from Financing Activities
₪6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rekah Pharmaceutical Industry Ltd's Cash from Financing Activities?
Cash from Financing Activities
-7.8m
ILS
Based on the financial report for Dec 31, 2023, Rekah Pharmaceutical Industry Ltd's Cash from Financing Activities amounts to -7.8m ILS.
What is Rekah Pharmaceutical Industry Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-20%
Over the last year, the Cash from Financing Activities growth was 68%.